Beijing Jiquan Biotechnology Co., Ltd.

Taking "the change in VAS score of joint pain compared with baseline after the end of medication on the 7th day" as the main efficacy indicator, a randomized, double-blind, placebo-controlled, multicenter clinical trial design was adopted to preliminarily evaluate the efficacy and safety of different doses of Tutengcao granules in the treatment of acute gouty arthritis (damp-heat accumulation syndrome), and provide a basis for Phase III clinical research.